Aspen Aerogels, Inc. $ASPN Holdings Lifted by MetLife Investment Management LLC

Key Points

• MetLife Investment Management LLC significantly increased its stake in Aspen Aerogels by 2,036.3%, owning approximately 764,423 shares valued at about $4.89 million as of its latest SEC filing.
• Aspen Aerogels stock is currently down 1.9%, opening at $6.83, with a market capitalization of $562.52 million and a negative net margin of 78.53%.
• Analysts have mixed opinions on Aspen Aerogels, with price target adjustments reflecting a consensus target of $19.50, while ratings range from "Strong Buy" to "Sell."

MetLife Investment Management LLC lifted its stake in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) by 2,036.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 764,423 shares of the construction company's stock after purchasing an additional 728,641 shares during the quarter. MetLife Investment Management LLC owned about 0.93% of Aspen Aerogels worth $4,885,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. Invesco Ltd. grew its holdings in Aspen Aerogels by 3.5% in the 4th quarter. Invesco Ltd. now owns 50,871 shares of the construction company's stock worth $604,000 after buying an additional 1,724 shares in the last quarter. Alps Advisors Inc. grew its holdings in Aspen Aerogels by 1.7% in the 1st quarter. Alps Advisors Inc. now owns 126,326 shares of the construction company's stock worth $807,000 after buying an additional 2,093 shares in the last quarter. Journey Strategic Wealth LLC grew its holdings in Aspen Aerogels by 17.3% in the 1st quarter. Journey Strategic Wealth LLC now owns 17,596 shares of the construction company's stock worth $112,000 after buying an additional 2,596 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its holdings in Aspen Aerogels by 9.5% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 35,040 shares of the construction company's stock worth $416,000 after buying an additional 3,041 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Aspen Aerogels by 1,998.7% in the 1st quarter. GAMMA Investing LLC now owns 3,316 shares of the construction company's stock worth $210,000 after buying an additional 3,158 shares in the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CAO Santhosh P. Daniel sold 4,410 shares of Aspen Aerogels stock in a transaction on Tuesday, August 12th. The stock was sold at an average price of $7.31, for a total value of $32,237.10. Following the transaction, the chief accounting officer directly owned 19,879 shares in the company, valued at $145,315.49. The trade was a 18.16% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. 3.40% of the stock is owned by insiders.

Aspen Aerogels Price Performance

NYSE ASPN traded down $0.13 on Monday, reaching $6.83. 1,079,251 shares of the stock traded hands, compared to its average volume of 2,428,220. The company has a market cap of $562.52 million, a price-to-earnings ratio of -1.79 and a beta of 2.65. The company has a quick ratio of 3.31, a current ratio of 3.98 and a debt-to-equity ratio of 0.34. The firm's fifty day simple moving average is $7.03 and its 200 day simple moving average is $6.56. Aspen Aerogels, Inc. has a 12 month low of $4.16 and a 12 month high of $30.24.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its earnings results on Thursday, August 7th. The construction company reported ($0.04) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.08. The business had revenue of $78.02 million for the quarter, compared to analysts' expectations of $72.53 million. Aspen Aerogels had a positive return on equity of 2.92% and a negative net margin of 78.53%.The company's quarterly revenue was down 33.8% on a year-over-year basis. During the same period in the previous year, the firm posted $0.21 EPS. Aspen Aerogels has set its FY 2025 guidance at -3.860--3.730 EPS. As a group, research analysts predict that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages recently issued reports on ASPN. Canaccord Genuity Group decreased their price objective on Aspen Aerogels from $11.00 to $10.00 and set a "buy" rating for the company in a report on Friday, August 8th. Barclays lowered Aspen Aerogels from an "equal weight" rating to an "underweight" rating and increased their price target for the company from $7.00 to $16.00 in a research note on Monday, August 11th. Finally, Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 8th. One investment analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $19.50.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.